Polaramine and Systemic candida - a phase IV clinical study of FDA data

Summary:

Systemic candida is reported as a side effect among people who take Polaramine (dexchlorpheniramine maleate), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Levofloxacin, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Systemic candida when taking Polaramine. It is created by eHealthMe based on reports of 10,478 people who have side effects when taking Polaramine from the FDA, and is updated regularly.

What is Polaramine?

Polaramine has active ingredients of dexchlorpheniramine maleate. It is often used in allergic rhinitis. eHealthMe is studying from 10,531 Polaramine users. Check the latest studies of Polaramine.

What is Systemic candida?

Systemic candida (whole body fungal infection) is found to be associated with 278 drugs and 410 conditions by eHealthMe. Check the latest studies of Systemic candida.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

10,478 people reported to have side effects when taking Polaramine.
Among them, 13 people (0.12%) have Systemic candida.

Could Polaramine cause Systemic candida?

Among these 13 people:

How long have people been on Polaramine when they have Systemic candida? *

What is the gender of people who have Systemic candida when taking Polaramine? *

female: 23.08 %
male: 76.92 %

What is the age of people who have Systemic candida when taking Polaramine? *

What are other drugs people take besides Polaramine? *

What are other side effects people have besides Systemic candida? *

Tumor Lysis Syndrome: 5 people, 38.46%
Nausea And Vomiting: 5 people, 38.46%
Thrombocytopenia (decrease of platelets in blood): 5 people, 38.46%
Constipation: 4 people, 30.77%
Anaemia (lack of blood): 4 people, 30.77%
Fever: 4 people, 30.77%
Pneumonia: 4 people, 30.77%
Sepsis (a severe blood infection that can lead to organ failure and death): 3 people, 23.08%
Lymphocyte Count Decreased: 3 people, 23.08%
General Physical Health Deterioration (weak health status): 3 people, 23.08%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 3 people, 23.08%
Diabetes: 2 people, 15.38%
Pain: 2 people, 15.38%
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (long lasting infection of nerves outside brain and spinal cord): 2 people, 15.38%
Diarrhea: 1 person, 7.69%
Infection: 1 person, 7.69%
Immunodeficiency Disorders: 1 person, 7.69%
Hyperkalemia (damage to or disease of the kidney): 1 person, 7.69%
Fever: 1 person, 7.69%
Febrile Bone Marrow Aplasia (bone marrow greatly decreases or stops production of blood cells): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Polaramine and have Systemic candida?

- Check whether Systemic candida is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Polaramine:

Polaramine (10,531 reports)

Browse all side effects of Polaramine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Systemic candida:

Systemic candida (278 drugs)

Browse all the conditions that are associated with Systemic candida:

Systemic candida (410 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on dexchlorpheniramine maleate (the active ingredients of Polaramine) and Polaramine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.